Filing Details
- Accession Number:
- 0000899243-22-034264
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2022-10-26 16:15:45
- Reporting Period:
- 2022-10-20
- Accepted Time:
- 2022-10-26 16:15:45
- Original Submission Date:
- 2022-10-24
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1754068 | Allovir Inc. | ALVR | Biological Products, (No Disgnostic Substances) (2836) | 831971007 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1818802 | Ercem Atillasoy | C/O Allovir, Inc. 1100 Winter Street Waltham MA 02451 | See Remarks | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2022-10-20 | 568 | $9.36 | 132,899 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-10-21 | 1,527 | $8.48 | 131,372 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units, and does not represent a discretionary trade by the Reporting Person.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $9.08 to $9.72. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $8.40 to $8.61. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Billionaire Hedge Funds
